RadNet, Inc. (RDNT) Fair Value 2026

RDNT · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.7 /10

32 fundamental signals · 7 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-27, RadNet, Inc. (RDNT) trades at $75.36, versus a $31.45 median fair value across its 7 active models — 58.3% below the current price. QOC: 6.7/10. Value Trap Risk: 0/100 (SAFE). 7/13 models active. Within that set, the Bayesian DCF component alone returns $9.89.

Key Facts

Ticker
RDNT
Price
$75.36
Quality Score
6.7/10
Value Trap Risk
0/100
Models Active
7/13
Last Updated
Strength: 7 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is RadNet, Inc. (RDNT) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, RadNet, Inc. (RDNT) appears overvalued as of : the median of 7 independent fair value estimates is $31.45, 58.3% below the current price of $75.36. Estimates range from $9.89 to $62.68. RDNT scores 6.7/10 on fundamental quality and 0/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. RDNT’s -58.3% gap is wider than that market norm, and the Diagnostics & Research sector median is -54.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy RadNet, Inc. Stock in 2026? →

What Fair Value Does Each Model Give RDNT?

7 Intrinsic Value Models vs. Current Price ($75.36)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $9.89 -86.9%
Ensemble · Medium Conviction
 $31.45 -58.3%
Scenario · High Conviction
 $62.68 -16.8%
Unlock the Full Matrix

Access 4 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is RDNT's Fair Value Range?

Spread across 7 independent models · $9.89 to $62.68

CirclFi's 7 active models place RadNet, Inc. (RDNT) between $9.89 and $62.68 per share, a spread of 168% of the median. The median of that range — $31.45 — is the fair value CirclFi publishes for RDNT, against a current price of $75.36.

Low · Bayesian DCFHigh · First Chicago
$9.89median $31.45$62.68
Where the range comes from
Most bearish modelBayesian DCF$9.89
Most bullish modelFirst Chicago$62.68
Model agreement0 bullish · 7 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for RDNT. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on RDNT, not a CirclFi price target. How each model works →

What Is RadNet, Inc. (RDNT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, RadNet, Inc.'s intrinsic value is estimated at $31.45. Trading at its current price of $75.36, the valuation engine raises significant caution: 7 of 7 models flag downside risk, projecting a median implied return of -58.3%. The most optimistic model, First Chicago, places fair value at $62.68 (-16.8%), while Bayesian DCF — the most conservative — estimates $9.89 (-86.9%). This +70.0% gap reflects genuine analytical uncertainty about RadNet, Inc.'s intrinsic worth.

What Do the Models Say About RDNT?

7 of 13 models are currently active for RDNT. All 7 active models suggest the stock trades above fair value. Taken together, their median fair value for RDNT is $31.45 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $9.89 on its own, implying -86.9% downside from the current price. See which stocks rank higher →

How Does RDNT Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, RDNT ranks #28 by Quality of Company score. CirclFi's QOC score of 6.7/10 evaluates 32 fundamental signals. A score of 6.7 indicates above-average quality.

RadNet, Inc.'s positioning within the Diagnostics & Research segment means that biosimilar competition timeline plays an outsized role in fundamental analysis. The sector's unique characteristics — including licensing and M&A optionality — shape both the opportunity set and risk profile.

Is RDNT a Value Trap?

CirclFi's Value Trap algorithm assigns RDNT a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for RadNet, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, RadNet, Inc. earns a quality score of 6.7/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +70.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every RDNT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across RDNT's 7 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy RadNet, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

10 related Diagnostics & Research stocks with 13-model coverage

XGNExagen Inc.QOC 6.7NEONeoGenomics, Inc.QOC 6.6PRPOPrecipio, Inc.QOC 6.7MYGNMyriad Genetics, Inc.QOC 6.6CRLCharles River Laboratories International, Inc.QOC 6.9BNRBurning Rock Biotech LimitedQOC 6.5ADVBAdvanced Biomed Inc.QOC 5.0MEDPMedpace Holdings, Inc.QOC 9.3LHLabcorp Holdings Inc.QOC 7.7IDXXIDEXX Laboratories, Inc.QOC 9.5

Read investment analysis: XGN · NEO · PRPO · MYGN · CRL · BNR · ADVB · MEDP · LH · IDXX

Which Other Stocks Have a Similar Quality Score to RDNT?

7 companies across all industries closest to RDNT’s Quality of Company score of 6.7/10.

SILCSilicom Ltd.QOC 6.7INLXIntellinetics, Inc.QOC 6.7MRKRMarker Therapeutics, Inc.QOC 6.7BZHBeazer Homes USA, Inc.QOC 6.7NSPInsperity, Inc.QOC 6.7PACKRanpak Holdings Corp.QOC 6.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SILC · INLX · MRKR · BZH · NSP · PACK · NVDA

What Else Do Investors Ask About RadNet, Inc.’s Valuation?

What is RadNet, Inc.'s intrinsic value in 2026?

CirclFi puts RadNet, Inc. (RDNT)'s intrinsic value at $31.45 — the median of 7 independent model estimates as of 2026-08-27, ranging from $9.89 to $62.68. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $9.89 on its own. The Quality of Company score is 6.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is RDNT overvalued or undervalued right now?

At $75.36, 0 of 7 active models suggest RDNT may be undervalued, while 7 indicate potential overvaluation. The median of all 7 fair value estimates is $31.45, 58.3% below the current price of $75.36 — a consensus view that RDNT is overvalued. The assessment depends on which methodology best fits RadNet, Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 6.7 mean for RDNT?

RadNet, Inc.'s QOC of 6.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on RDNT?

CirclFi analyzes RDNT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on RDNT?

Of the 7 models currently active on RDNT, First Chicago is the most bullish at $62.68 per share, and Bayesian DCF is the most bearish at $9.89. CirclFi's published fair value for RDNT is the median of that range, $31.45, not either extreme. The gap between the two ends equals 168% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is RDNT a value trap in 2026?

RadNet, Inc.'s Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 7-model valuation engine, RadNet, Inc. (RDNT) has a median fair value of $31.45 — 58.3% below the current price of $75.36 — as of 2026-08-27.” Source: circlfi.com/stock/RDNT/ · Methodology
Primary sources for this RDNT valuation
  • Financial statements: RadNet, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000790526) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for RDNT as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on RDNT.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for RDNT Unlock All 7 — $39/mo